RANCHO CORDOVA, Calif., March 20, 2019 /PRNewswire/ -- Cesca Therapeutics Inc.á(Nasdaq: KOOL), a market leader in automatedcellularáprocessing and autologous cell therapies for regenerative medicine, today announcedáthatáthe Company will release its financial results for the fourth quarter ended December 31, 2018 on Monday,
To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit:https://services.choruscall.com/links/kool190321.html.
A replay of the call will be available until April 11 and can be accessed by dialing 1-877-344-7529á(domestic), 1-412-317-0088 (international) or 855-669-9658 (Canada) and referencing access code 10128593. The webcast will be available for three months.
About Cesca Therapeutics Inc.áCesca Therapeutics Inc.áis a market leader in cell processing technologies and autologous cell therapies for regenerative medicine.áItsádevice division, ThermoGenesis, develops, commercializes and markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. The Company'sá automated, functionally-closed CAR-TXpressÖ platform is designed to streamline the manufacturing process for the emerging CAR-T immunotherapy market.áFor more information, visit: www.thermogenesis.comáand www.cescatherapeutics.com.
Company Contact:Cesca Therapeutics Inc.áWendy Samfordá916-858-5191áir@cescatherapeutics.comá
Investor Contact:Rx CommunicationsáPaula Schwartzá917-322-2216ápschwartz@rxir.com
View original content:http://www.prnewswire.com/news-releases/cesca-therapeutics-to-announce-financial-results-for-the-fourth-quarter-ended-december-31-2018-and-host-conference-call-on-march-25-300815336.html
SOURCE Cesca Therapeutics Inc.
Subscribe to our Free Newsletters!